BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 958534)

  • 1. The metastatic spread of kidney and prostate cancers in man.
    Viadana E; Bross ID; Pickren JW
    Neoplasma; 1976; 23(3):323-32. PubMed ID: 958534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors in prostate cancer metastasis.
    Geldof AA; Rao BR
    Anticancer Res; 1990; 10(5A):1303-6. PubMed ID: 2241106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidence and nature of metastases of prostatic cancer based on autopsy data].
    Makarova GV; Gorilovskiĭ LM; Okunev DIu
    Vopr Onkol; 1987; 33(4):78-83. PubMed ID: 3590663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of metastases in adenocarcinomas of man. An autopsy study of 4,728 cases.
    Viadana E; Au K-L
    J Med; 1975; 6(1):1-14. PubMed ID: 1056412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone.
    Rajan R; Vanderslice R; Kapur S; Lynch J; Thompson R; Djakiew D
    Prostate; 1996 Jan; 28(1):1-9. PubMed ID: 8545275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Nod Scid mouse model to study human prostate cancer.
    Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
    Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin treatment increases metastasis of prostate tumor (R3327-MatLyLu).
    Geldof AA; Rao BR
    Anticancer Res; 1988; 8(6):1335-9. PubMed ID: 3218966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
    Pettaway CA; Pathak S; Greene G; Ramirez E; Wilson MR; Killion JJ; Fidler IJ
    Clin Cancer Res; 1996 Sep; 2(9):1627-36. PubMed ID: 9816342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic dissemination of B16 melanoma: pattern and sequence of metastasis.
    Alterman AL; Fornabaio DM; Stackpole CW
    J Natl Cancer Inst; 1985 Oct; 75(4):691-702. PubMed ID: 3862901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic prostate cancer in a transgenic mouse.
    Gingrich JR; Barrios RJ; Morton RA; Boyce BF; DeMayo FJ; Finegold MJ; Angelopoulou R; Rosen JM; Greenberg NM
    Cancer Res; 1996 Sep; 56(18):4096-102. PubMed ID: 8797572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastasis of renal adenocarcinoma.
    Saitoh H; Shimbo T; Tasaka T; Iida T; Hara K
    Tokai J Exp Clin Med; 1982 May; 7(3):337-43. PubMed ID: 7123572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metastatic spread of "head and neck" tumors in men (an autopsy study of 371 cases).
    Viadana E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1975 Aug; 83(4):293-304. PubMed ID: 125959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
    Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
    Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of metastatic bone disease and risk of skeletal morbidity.
    Coleman RE
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
    Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
    Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional lymph node metastases; a singular manifestation of the process of clinical metastases in cancer: contemporary animal research and clinical reports suggest unifying concepts.
    Cady B
    Ann Surg Oncol; 2007 Jun; 14(6):1790-800. PubMed ID: 17342568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.